Product information and disease descriptionPlace of product in therapyApproaches to treatment
Care management intervention strategies
6 evidence topics · 8 sources
Continuous glucose monitoring in insulinoma
“A continuous glucose monitoring system can support patients in recognizing hypoglycemic events and prevent serious complications, especially during the night” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Patients with insulinoma frequently have impaired hypoglycaemia awareness and evaluating treatment effect by symptoms alone may miss asymptomatic hypoglycaemia” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“We advocate the use of continuous glucose monitoring in patients with insulinoma to reduce the incidence of severe hypoglycaemic episodes and enable dietary and medical intervention to be tailored for the individual and their lifestyle.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Dietitian-led nutritional management and patient and family education in insulinoma
“Early education on hypoglycaemia identification and treatment for the patient and their family is critical.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Patients with insulinoma should have specialist dietitian assessment and follow up comprising regular assessment of glycaemic control, nutritional education and intervention.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Multidisciplinary team and tumor board management
Multidisciplinary eligibility review and coordination of tumor-directed therapy during ersodetug treatment
“Individuals resumed tumor-directed therapies or procedures as deemed appropriate by the multidisciplinary clinical care team, and these interventions were systematically recorded as part of the observational dataset.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Monitoring for hypoglycemia flare during PRRT
“Side-effects included G3/4 myelosuppression in 4/15 patients and hypoglycaemia flare (hospitalisation >48 h) in 7/15 patients.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“PRRT provides durable hypoglycaemic and oncologic disease control of MI with manageable toxicity including hypoglycaemia flare requiring multidisciplinary care.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Palliative care coordination at the end of life in metastatic insulinoma
“Hypoglycaemia is a common cause of death for patients with metastatic insulinoma, whose disease has progressed despite multiple lines of therapy.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Declining oral intake, anxiety around symptoms of hypoglycaemia, complex emotions regarding the cessation of CGM and difficulty in managing other symptoms such as pain should be navigated together with palliative care clinicians” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote